| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ML239 | CTRPv2 | pan-cancer | AAC | -0.052 | 0.1 |
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | 0.083 | 0.1 |
| mRNA | Tamoxifen | CTRPv2 | pan-cancer | AAC | 0.055 | 0.1 |
| mRNA | pandacostat | CTRPv2 | pan-cancer | AAC | 0.054 | 0.1 |
| mRNA | QW-BI-011 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.1 |
| mRNA | Merck60 | CTRPv2 | pan-cancer | AAC | 0.043 | 0.1 |
| mRNA | temsirolimus | CTRPv2 | pan-cancer | AAC | 0.067 | 0.1 |
| mRNA | salermide:PLX-4032 (12:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.053 | 0.2 |
| mRNA | CD-437 | CTRPv2 | pan-cancer | AAC | 0.046 | 0.2 |
| mRNA | BRD4132 | CTRPv2 | pan-cancer | AAC | 0.054 | 0.2 |